VISUALLY SPEAKING
Presumed Tenofovir Toxicity
A patient’s medication history led to retinal atrophy and other findings.
By Navneet Mehrotra, MBBS, DNB, FRF; Manish Nagpal, MBBS, MS, FRCS; and Sham Talati, DO
Donut-Shaped Subhyaloidal Hemorrhage
The peculiar shape led to the preservation of good vision.
By Sebastian M. Waldstein, MD, PhD; Ji Li, MBBS; and Adrian T. Fung, MBBS, MMED, FRANZCO
SPOTLIGHT COVERAGE ON AGE-RELATED MACULAR DEGENERATION
OCT Angiography in Nonexudative Age-Related Macular Degeneration
Will this imaging modality lead to better assessment of patients with dry eye disease?
By Luísa S.M. Mendonça, MD; and Caroline R. Baumal, MD

Real-World Injection Intervals in Wet AMD
Aided by a large database, researchers explore treatment patterns with anti-VEGF agents.
By Mathew W. MacCumber, MD, PhD

Photobiomodulation as a Treatment in Dry AMD
Doctors and patients have found this new mode of therapy beneficial.
By Hakan Kaymak, MD; and Hartmut Schwahn, PhD
ONCOLOGY

Every Millimeter Counts for Nevus Transformation Into Malignant Melanoma
A summary of my 2019 Wendell L. Hughes Lecture.
By Carol L. Shields, MD
SURGICAL PEARLS
Lessons for Future Attendings
Answers to questions about managing surgical complications and teaching trainees.
Interview by Nimesh Patel, MD; and Nicolas Yannuzzi, MD; With Jayanth Sridhar, MD
MEDICAL RETINA
Controlling Flares in Chronic Noninfectious Uveitis
Two fluocinolone acetonide formulations—a newly approved one and a familiar one—offer options for long-term inflammation control.
By Stephen D. Anesi, MD, FACS; and Peter Y. Chang, MD
GLOBAL PERSPECTIVES

The Mother of Invention: Making Custom Equipment in Syria
Developing a custom-made needle for suprachoroidal steroid injections in Syria.
By Ameen Marashi, MD; and Benjamin J. Thomas, MD
CONTINUING COVERAGE OF COVID-19 IN RETINA

How COVID-19 May Change the Future of Retina Practice
When we think of what the future may hold, it behooves us to think from a public health perspective.
By Rahul Reddy, MD, MHS
Open Globe Injury in COVID-19 Patient: Lessons Learned
Special precautions are required to safely and quickly treat patients with potential infection.
By Vamsee Neerukonda, MD; Kevin Rosenberg, MD; and Patrick Oellers, MD
Literature Review: Eye Care in the Era of COVID-19
Two studies have implications for improving the safety of patients and providers during the current pandemic.
By Cara E. Capitena Young, MD; and Malik Y. Kahook, MD
Curbing Our Enthusiasm for Telemedicine and Deciding on Treatments During COVID-19
COVID-19 has changed the way we think about telemedicine and treatment decisions. Is retina ready for telemedicine? How much have treatment decisions actually changed?
By David A. Eichenbaum, MD
Telehealth Implementation in Retina Practices During COVID-19
Retina specialists can use this time to gather information about the feasibility of teleophthalmology consultations.
By Edward S. Lu, BA; S.K. Steven Houston III, MD; Ehsan Rahimy, MD; and John B. Miller, MD
Convention Updates
Many ophthalmology meetings set to be held this spring have been rescheduled, postponed, or canceled. This list is accurate as of Retina Today’s press date in mid-May.